» Articles » PMID: 23037870

CD117(+) Amniotic Fluid Stem Cells: State of the Art and Future Perspectives

Overview
Journal Organogenesis
Date 2012 Oct 6
PMID 23037870
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Broadly multipotent stem cells can be isolated from amniotic fluid by selection for the expression of the membrane stem cell factor receptor c-Kit, a common marker for multipotential stem cells. They have clonogenic capability and can be directed into a wide range of cell types representing the three primary embryonic lineages. Amniotic fluid stem cells maintained for over 250 population doublings retained long telomeres and a normal karyotype. Clonal human lines verified by retroviral marking were induced to differentiate into cell types representing each embryonic germ layer, including cells of adipogenic, osteogenic, myogenic, endothelial, neuronal and hepatic lineages. AFS cells could be differentiate toward cardiomyogenic lineages, when co-cultured with neonatal cardiomyocytes, and have the potential to generate myogenic and hematopoietic lineages both in vitro and in vivo. Very recently first trimester AFS cells could be reprogrammed without any genetic manipulation opening new possibilities in the field of fetal/neonatal therapy and disease modeling. In this review we are aiming to summarize the knowledge on amniotic fluid stem cells and highlight the most promising results.

Citing Articles

Stem Cells in Bone Tissue Engineering: Progress, Promises and Challenges.

Augustine R, Gezek M, Nikolopoulos V, Buck P, Bostanci N, Camci-Unal G Stem Cell Rev Rep. 2024; 20(7):1692-1731.

PMID: 39028416 DOI: 10.1007/s12015-024-10738-y.


Amniotic fluid-derived small extracellular vesicles for predicting postnatal severe outcome of congenital diaphragmatic hernia.

Matsuo S, Yokoi A, Yoshida K, Kitagawa M, Asano-Inami E, Miura M J Extracell Biol. 2024; 3(6):e160.

PMID: 38947173 PMC: 11212330. DOI: 10.1002/jex2.160.


PCR Array Profiling of miRNA Expression Involved in the Differentiation of Amniotic Fluid Stem Cells toward Endothelial and Smooth Muscle Progenitor Cells.

Iordache F, Petcu A, Pisoschi A, Stanca L, Geicu O, Bilteanu L Int J Mol Sci. 2024; 25(1).

PMID: 38203477 PMC: 10779355. DOI: 10.3390/ijms25010302.


Tissue-specific populations from amniotic fluid-derived mesenchymal stem cells manifest variant in vitro and in vivo properties.

Liu N, Cheng Y, Wang D, Guan H, Chen D, Zeng J Hum Cell. 2023; 37(2):408-419.

PMID: 38085460 PMC: 10891244. DOI: 10.1007/s13577-023-01008-z.


Combination of human platelet lysate and 3D gelatin scaffolds to enhance osteogenic differentiation of human amniotic fluid derived mesenchymal stem cells.

Yaja K, Aungsuchawan S, Narakornsak S, Pothacharoen P, Pantan R, Tancharoen W Heliyon. 2023; 9(8):e18599.

PMID: 37576189 PMC: 10413082. DOI: 10.1016/j.heliyon.2023.e18599.


References
1.
Bianco P, Robey P . Stem cells in tissue engineering. Nature. 2001; 414(6859):118-21. DOI: 10.1038/35102181. View

2.
Gidekel S, Pizov G, Bergman Y, Pikarsky E . Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell. 2003; 4(5):361-70. DOI: 10.1016/s1535-6108(03)00270-8. View

3.
Warren L, Manos P, Ahfeldt T, Loh Y, Li H, Lau F . Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell. 2010; 7(5):618-30. PMC: 3656821. DOI: 10.1016/j.stem.2010.08.012. View

4.
Gosden C, Brock D . Amniotic fluid cell morphology in early antenatal prediction of abortion and low birth weight. Br Med J. 1978; 2(6146):1186-9. PMC: 1608358. DOI: 10.1136/bmj.2.6146.1186. View

5.
Narsinh K, Jia F, Robbins R, Kay M, Longaker M, Wu J . Generation of adult human induced pluripotent stem cells using nonviral minicircle DNA vectors. Nat Protoc. 2011; 6(1):78-88. PMC: 3657506. DOI: 10.1038/nprot.2010.173. View